Injective surged 46.78% in Q2, while daily active addresses soared 1,500%, confirming rising investor and network traction.
INJ defended the $10 level after spiking to $15 in May, showing strong buyer support and resilient Layer 1 performance.
INJ ranked second behind SUI in L1 gains, with both tokens drawing capital flows while majors like BTC and ETH stayed flat.
Injective (INJ) climbed 46.78% over the past quarter, marking it as the second-best performing Layer 1 protocol. Alongside price gains, Injective's on-chain usage spiked as daily active addresses hit 82,500 in July, confirming significant network momentum.
Daily Activity on Injective Hits 82.5K in Record Surge
Injective has seen a 1,500% spike in daily active addresses since January, reaching 82,500 by early July. In a post by LennaertSnyder, the analyst noted, “Injective is growing exponentially and this is just the beginning,” referencing data from Token Terminal.
Activity remained flat between Q3 2024 and Q1 2025 before rising sharply in mid-March. The metric continued accelerating through Q2, despite a mid-June pullback, signaling consistent protocol usage.
Momentum intensified from April onward, forming a vertical curve into Q3. This parabolic structure confirms Injective’s ongoing traction as network interactions break historical records.
Injective Price Holds Firm as Bulls Defend $10 Zone
INJ is priced at $10.86, showing a 2.9% daily increase against the U.S. dollar and ranking #88 overall. According to data from CoinGecko, its market cap stands at $1.05 billion, with current trades around 0.0001002 BTC and 0.004306 ETH.
Price surged in May with a breakout move from $9 to nearly $15, forming one of the quarter’s strongest single-week candles. Since then, INJ retraced lower but continues to hold support above $10, anchored by sustained buyer presence.
A visible long wick near $9.30 marked strong defense from bulls in late June. Three consecutive red candles were followed by smaller green bodies, showing early signs of price absorption within the $10–$12 range.
Q2 Rotation Favored Injective and SUI Among L1 Tokens
INJ ranked second in performance behind SUI, which gained 61.72% between April and July. SOL trailed with 37.53%, while TRX and BNB delivered smaller gains at 23.99% and 17.96% respectively, according to data shared by LennaertSnyder.
https://twitter.com/LennaertSnyder/status/1941450064804880686
Ethereum, Bitcoin, and BNB posted flatter trends, suggesting slower rotational interest compared to smaller-cap Layer 1s. Injective and SUI both printed sharp rallies with visible pullbacks, indicating strong market participation and directional volatility.
Most Layer 1 tokens peaked between mid-May and early June before entering sideways movement. Yet, Injective and Solana held structurally stronger, reflecting deeper buyer conviction and persistent upside momentum among L1 traders.
The post INJ Gains 46% in 90 Days While Ethereum and Bitcoin Flatten Out appears on Coin Futura. Visit our website to read more interesting articles about cryptocurrency, blockchain technology, and digital assets.
